Thomas Edwards

Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2

Ana I. Cubas-Atienzar, Konstantina Kontogianni, Thomas Edwards et al. · Scientific Reports · 2021 · 109 citations · Full text

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B

Alasdair T. M. Hubbard, Jenifer Mason, Paul Roberts et al. · Nature Communications · 2020 · 83 citations · Full text

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 76 citations · Full text

Vaccination, Covid-19 Pandemic, Vaccine Trial +8

Characterization of <i>Bacteroides asaccharolyticus</i> and <i>B</i>. <i>melaninogenicus</i> oral isolates

D. Mayrand, B C McBride, Thomas Edwards et al. · Canadian Journal of Microbiology · 1980 · 70 citations

Phenylacetic Acid Production, Protease Activities, Pathogenic Microbiology +11

Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological study

Thayane Santos Siqueira, José Rodrigo Santos Silva, Mariana do Rosário Souza et al. · The Lancet Regional Health - Americas · 2021 · 55 citations · Full text